ResMed (RMD) Misses Q1 EPS by 2c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $221.97 --0%
Revenue Growth %: +6.9%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +6.9%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.62, $0.02 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $465.4 million versus the consensus estimate of $474.73 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Worthington Industries (WOR) Tops Q1 EPS by 7c
- Nike (NKE) PT Raised to $55 at BTIG
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
